reference/26357604

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/26357604

Outgoing Links

Predicate	Object
contentType	Journal Article
issn	1465-5411 1465-542X
issueIdentifier	1
pageRange	110-
publicationName	Breast cancer research : BCR
startingPage	110
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_e8ba04aa2a241635fa017269e5cc19ae http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b3eb645e9cd0db5cec6c05ec8f2cadfe http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_c144f14f6266b417ae01681697772850 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_7e9a36d24e8311942babff030f193e70 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_d50832d06b1e3eecfc67f577a310f6f7 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_32bce7b54e9e13b0719210c66ccb9df1 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_cbbc01f21eaafc738f56949299f85af2 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_8f96050c5628f19e155dc3eb5e36de48 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_33605f6d1a3e4561ee69fa452f8545ca http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_735c312c3a9922a78cdb757266d83c4c http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_7ce659d317d2f06ae96ed7f551bbefdb
bibliographicCitation	Johansson H, Gray KP, Pagani O, Regan MM, Viale G, Aristarco V, Macis D, Puccio A, Roux S, Maibach R, Colleoni M, Rabaglio M, Price KN, Coates AS, Gelber RD, Goldhirsch A, Kammler R, Bonanni B, Walley BA, the TEXT principal investigators. Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial. Breast Cancer Research. 2016 Nov 08;18(1):110. doi: 10.1186/s13058-016-0771-8.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9eb672de6beed62ea552e945cfcda729 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0023d2694e2e871be525d77f085c9162 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a046026f633ed54a7d52a9b19df3cfe9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5743-3013 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_59fff6259fc5898329c73ab2fa8d336d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c208726555ffffbf677f3c5868fb179e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c12ad27e5b42a42a86a20f79abc3dabb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ac2cf78b2812e49427eedc40fb356900 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fca859412823435a2e37a5bd7cc07c9e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7859fcbf4c0bda6fe2c5f3e8e84fba37 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_be98f459b7fe9fae0486c729e0cd1a56 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-4131-2030 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bc01fcc0137bfca6c3cd7367fb73b30f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ab1f681f3ef6365031fef78ee55ea331 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a9a211a047ba69fe4f9df3d386e1a699 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7682a036e89fd99eb1f7cddcb70b064c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9234f89b41880c1b4c51255ed9744d49 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5710648a5b9031fbdc67f99e42e897d3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_78b3a940de3d9245855642233bd23253 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d5c9179cec40fe12a536c84157a46e2c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_33ba290533f12c7aff8281c18189224a
date	2016-11-08^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/27825388 https://doi.org/10.1186/s13058-016-0771-8 https://pubmed.ncbi.nlm.nih.gov/PMC5101790
isPartOf	https://portal.issn.org/resource/ISSN/1465-5411 https://portal.issn.org/resource/ISSN/1465-542X http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21884
language	English
source	https://scigraph.springernature.com/ https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial
discusses	http://id.nlm.nih.gov/mesh/M0493336 http://id.nlm.nih.gov/mesh/M0561470 http://id.nlm.nih.gov/mesh/M0280632 http://id.nlm.nih.gov/mesh/M0001707
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000971Q000009 http://id.nlm.nih.gov/mesh/D047628Q000235 http://id.nlm.nih.gov/mesh/D064420Q000235 http://id.nlm.nih.gov/mesh/D001141Q000235 http://id.nlm.nih.gov/mesh/D001943Q000235 http://id.nlm.nih.gov/mesh/D000071184 http://id.nlm.nih.gov/mesh/D014644
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D012307 http://id.nlm.nih.gov/mesh/D016032 http://id.nlm.nih.gov/mesh/D001943Q000401 http://id.nlm.nih.gov/mesh/D001943Q000188 http://id.nlm.nih.gov/mesh/D019584Q000235 http://id.nlm.nih.gov/mesh/D017326 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D016017 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D013546Q000235
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2733526 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_5d445780815638f183c8f68566998507 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10389 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_26e3b3a0ea8ee6116067a3b73abe7e5c http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60198 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1588

Showing number of triples: 1 to 84 of 84.